Form 8-K - Current report:
SEC Accession No. 0001415889-17-001903
Filing Date
2017-12-08
Accepted
2017-12-08 13:27:11
Documents
3
Period of Report
2017-12-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-12082017_101201.htm 8-K 29494
2 ex99-12082017_101202.htm EX-99 13018
3 graphic-12082017_051231.jpg GRAPHIC 11379
  Complete submission text file 0001415889-17-001903.txt   59514
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 171246723
SIC: 2834 Pharmaceutical Preparations